CD274 and neoplasm: In addition, an IC (immune cells) score with recognition of an >10% area occupied by PD-L1-positive immune cells (lymphocytes, dendritic cells, macrophages, and granulocytes) in the whole tumor area is also known as a predictive marker of tumor response to immune checkpoint-inhibitor therapy [6,7,8].